Literature DB >> 28244597

Interleukin-37 elevation in patients with atrial fibrillation.

Weidong Li1, Shijie Li1, Xianjin Li1, Shuzhong Jiang1, Bing Han1.   

Abstract

BACKGROUND: Inflammation is closely related to atrial fibrillation (AF) pathogenesis, and interleukin-37 (IL-37) represents a new member of the anti-inflammatory cytokines. HYPOTHESIS: IL-37 might play an important role in AF development and act as a potential risk factor for AF diagnosis.
METHODS: The mRNA level of IL-37 in peripheral blood mononuclear cells (PBMCs) and serum IL-37 levels in AF patients and healthy controls were measured by real-time polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA). PBMCs from AF patients were stimulated with recombinant IL-37. Levels of pro-inflammatory cytokines IL-6 and C-reactive protein were determined by RT-PCR and ELISA.
RESULTS: IL-37 mRNAs and serum protein levels were higher in patients with AF or lone AF compared with healthy controls. Patients with paroxysmal AF or persistent AF showed higher IL-37 mRNAs and serum protein levels compared with those with permanent AF as well as healthy controls. In vitro, IL-37 inhibited the production of IL-6 and C-reactive protein in PBMCs of patients with AF.
CONCLUSIONS: IL-37 is elevated in AF patients and its expression is closely associated with AF subgroups. Thus, IL-37 may provide a novel research target for the pathogenesis and therapy of AF. This study is the first to document elevated IL-37 in AF patients.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  AF; Atrial Fibrillation; IL-37; Inflammation; Interleukin-37

Mesh:

Substances:

Year:  2016        PMID: 28244597      PMCID: PMC6490375          DOI: 10.1002/clc.22630

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  38 in total

1.  ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology.

Authors:  V Fuster; L E Rydén; R W Asinger; D S Cannom; H J Crijns; R L Frye; J L Halperin; G N Kay; W W Klein; S Lévy; R L McNamara; E N Prystowsky; L S Wann; D G Wyse; R J Gibbons; E M Antman; J S Alpert; D P Faxon; V Fuster; G Gregoratos; L F Hiratzka; A K Jacobs; R O Russell; S C Smith; W W Klein; A Alonso-Garcia; C Blomström-Lundqvist; G de Backer; M Flather; J Hradec; A Oto; A Parkhomenko; S Silber; A Torbicki
Journal:  Circulation       Date:  2001-10-23       Impact factor: 29.690

2.  Direct proinflammatory effect of C-reactive protein on human endothelial cells.

Authors:  V Pasceri; J T Willerson; E T Yeh
Journal:  Circulation       Date:  2000-10-31       Impact factor: 29.690

3.  C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation.

Authors:  M K Chung; D O Martin; D Sprecher; O Wazni; A Kanderian; C A Carnes; J A Bauer; P J Tchou; M J Niebauer; A Natale; D R Van Wagoner
Journal:  Circulation       Date:  2001-12-11       Impact factor: 29.690

4.  High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.

Authors:  P M Ridker
Journal:  Circulation       Date:  2001-04-03       Impact factor: 29.690

5.  The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication?

Authors:  Mario Gaudino; Felicita Andreotti; Roberto Zamparelli; Augusto Di Castelnuovo; Giuseppe Nasso; Francesco Burzotta; Licia Iacoviello; Maria Benedetta Donati; Rocco Schiavello; Attilio Maseri; Gianfederico Possati
Journal:  Circulation       Date:  2003-09-09       Impact factor: 29.690

6.  Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation.

Authors:  Dwayne S g Conway; Peter Buggins; Elizabeth Hughes; Gregory Y H Lip
Journal:  Am Heart J       Date:  2004-09       Impact factor: 4.749

7.  Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Eric P Leip; Philip A Wolf; Ralph B D'Agostino; Joanne M Murabito; William B Kannel; Emelia J Benjamin
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

Review 8.  Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress.

Authors:  Panagiotis Korantzopoulos; Theofilos Kolettis; Kostas Siogas; John Goudevenos
Journal:  Med Sci Monit       Date:  2003-09

9.  A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study.

Authors:  Thomas J Wang; Joseph M Massaro; Daniel Levy; Ramachandran S Vasan; Philip A Wolf; Ralph B D'Agostino; Martin G Larson; William B Kannel; Emelia J Benjamin
Journal:  JAMA       Date:  2003-08-27       Impact factor: 56.272

10.  Inflammation as a risk factor for atrial fibrillation.

Authors:  Ronnier J Aviles; David O Martin; Carolyn Apperson-Hansen; Penny L Houghtaling; Pentti Rautaharju; Richard A Kronmal; Russell P Tracy; David R Van Wagoner; Bruce M Psaty; Michael S Lauer; Mina K Chung
Journal:  Circulation       Date:  2003-11-17       Impact factor: 29.690

View more
  4 in total

Review 1.  Inflammasomes and Proteostasis Novel Molecular Mechanisms Associated With Atrial Fibrillation.

Authors:  Na Li; Bianca J J M Brundel
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

Review 2.  Potential role of IL-37 in atherosclerosis.

Authors:  Sara McCurdy; Chloe A Liu; Jonathan Yap; William A Boisvert
Journal:  Cytokine       Date:  2017-10-05       Impact factor: 3.861

3.  Serum Interleukin-37 Increases in Patients after Ischemic Stroke and Is Associated with Stroke Recurrence.

Authors:  Ying Zhang; Chengbi Xu; Haitao Wang; Shanji Nan
Journal:  Oxid Med Cell Longev       Date:  2021-04-13       Impact factor: 6.543

4.  Marine-Derived Piericidin Diglycoside S18 Alleviates Inflammatory Responses in the Aortic Valve via Interaction with Interleukin 37.

Authors:  Shunyi Li; Jianglian She; Jingxin Zeng; Kaiji Xie; Zichao Luo; Shuwen Su; Jun Chen; Gaopeng Xian; Zhendong Cheng; Jing Zhao; Shaoping Li; Xingbo Xu; Dingli Xu; Lan Tang; Xuefeng Zhou; Qingchun Zeng
Journal:  Oxid Med Cell Longev       Date:  2022-08-17       Impact factor: 7.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.